Chembio Diagnostics announces it has been awarded a conditional Long Term Arrangement from UNICEF for purchases of the DPP Zika System, which is subject to Chembio satisfying certain conditions, including receipt of World Health Organization Emergency Use Assessment and Listing (EUAL), completion of clinical and analytical performance evaluation, and a successful quality management system (QMS) inspection. UNICEF is collaborating with partners, such as WHO and the Pan American Health Organization (PAHO), to make commercially available POC diagnostics for Zika virus. Chembio Diagnostics has developed and patented the DPP technology platform, which offers advantages over traditional POC lateral-flow technologies.